FDA peptide votes could open the door to more unproven drugs: ‘Pandora’s box’
A Food and Drug Administration advisory committee on Friday recommended allowing two more unproven peptides to be compounded,…
New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business Outlook
Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…
Can Ozempic rewire the addicted brain? : NPR
Part 1 of the TED Radio Hour episode Rethinking addiction in the age of Ozempic GLP-1s revolutionized weight-loss and diabetes…
Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills | Local News
LOUISVILLE, Ky. (WDRB/Gray Media) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another…
Pharmalittle: FDA panel backs pharmacies to make peptides
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients
GLP-1 medications have been shown to improve health and offer strong value for their price, yet many insurance…
Doctors are using a regulatory gap to prescribe an unauthorized peptide
Despite Health Canada’s warnings against the use of unauthorized peptides as a health and fitness shortcut, a CBC…
Lilly to file for next-gen obesity drug approval in early 2027
Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients
GLP-1 medications have been shown to improve health and offer strong value for their price, yet many insurance…
Health news round-up: coffee, ADHD prescribing, and GLP-1s and hair loss
The first cohort of MPharm pharmacist prescribers received their General Pharmaceutical Council (GPhC) registration results this week, with…
Novo’s Ozempic copy 15% cheaper, but Discovery still won’t change its position
Story audio is generated using AI Danish pharmaceutical manufacturer Novo Nordisk will launch its copy of its diabetes…
Australian regulator warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic | Health
Australia’s medicines regulator has issued warnings for several type 2 diabetes and obesity-related treatments – including Ozempic and…